Pulmonary hypertension trials recruiting in Ohio

All Pulmonary hypertension trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
  NCT07214376 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Ohio: Cleveland
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Ohio: Cincinnati
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Columbus
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati
• Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
  NCT02986087 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female · Ohio: Cincinnati
• Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
  NCT07477197 · Phase: Not specified · Ages: 16 Years and older · Sex: All (male and female) · Ohio: Cincinnati
• Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
  NCT06911632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Ohio: Cincinnati
• Safety and Efficacy of FETO in CDH Phase III
  NCT07187206 · Phase: Phase 3 · Ages: 18 Years to 50 Years · Sex: Female · Ohio: Cincinnati
• Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
  NCT04555161 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Columbus
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Cleveland